Related Experiment Video
Updated: Jun 1, 2026

Microfluidics in Assessing Platelet Function
Published on: November 8, 2024
Platelet response to aspirin and clopidogrel in patients with peripheral atherosclerosis
Esben Hjorth Madsen1, Norbert Rudolf Gehr, Nils Lauge Johannesen
1Department of Internal Medicine, Viborg Hospital , Heibergs Allé 4, 8800 Viborg, Denmark. ehmadsen@gmail.com
Insights
Assessing antiplatelet drug response in peripheral artery disease (PAD) patients reveals low aspirin response is rare, but high residual platelet reactivity is common and inconsistent. Clopidogrel response varies significantly by measurement method.
Area of Science:
- Cardiology
- Pharmacology
- Vascular Medicine
Background:
- Aspirin and clopidogrel are crucial for preventing ischemic events after treatment.
- Individual responses to these antiplatelet drugs vary, with high residual platelet reactivity being a risk factor.
- Peripheral artery disease (PAD) patients may show greater residual platelet reactivity than coronary heart disease patients.
Purpose of the Study:
- To compare the comparability of three platelet reactivity tests for assessing low response to aspirin and clopidogrel in PAD patients.
- To evaluate the consistency of platelet response measurements over time.
Main Methods:
- Compared Platelet Function Analyzer-100 (PFA), light transmission aggregometry (LTA), and whole blood impedance aggregometry (IA) in 263 PAD patients.
- Assessed platelet function twice, 3 months apart.
- Investigated the effect of a 600 mg clopidogrel dose on platelet function in 43 patients.
Main Results:
- Low response to aspirin (targeting cyclooxygenase-1 activity) was rare (≤ 8.1%) using LTA and IA.
- The PFA identified 17% with low aspirin response at both visits, with 23% showing inconsistent responses.
- Low response to clopidogrel varied from 0-23% depending on the method and criteria used.
Conclusions:
- Low aspirin response, defined by lack of COX-1 inhibition, is uncommon.
- High residual platelet reactivity, detected by PFA, is frequent in PAD patients but may not be consistent over time.
- The assessment of clopidogrel response is highly dependent on the specific assay and definition employed.
Abstract:
Aspirin and clopidogrel are important drugs in the secondary prevention of ischemic events. A considerable individual variation in platelet response to these drugs has, however, been reported, and high residual platelet reactivity despite treatment may be an independent risk factor for ischemic events. Most studies have been undertaken in patients with coronary heart disease, but patients with peripheral artery disease (PAD) may exhibit greater residual platelet reactivity, possibly because of platelet activation by a larger area of diseased endothelium. It is yet unsettled which method that best measures platelet reactivity and an eventual lack of response to aspirin. Several instruments are promoted to measure platelet response and low-response to platelet inhibitors, but it is questionable if they measure this in comparable ways. We studied the comparability of three tests of platelet reactivity for the assessment of low-response to aspirin and clopidogrel in patients with PAD. In 263 patients, platelet function was assessed twice, 3 months apart, by the Platelet Function Analyzer-100 (PFA), light transmission aggregometry (LTA), and whole blood impedance aggregometry (IA). In a subgroup of 43 patients, we studied the effect of a single dose of 600 mg clopidogrel on platelet function. Low-response to aspirin assessed by analyses targeting cyclooxygenase-1 activity (LTA, IA) was rare (≤ 8.1%). With the PFA, we found 17% with low response at both visits, and 60% who were consistently responsive, whereas 23% were categorized differently at the two visits. Low response to clopidogrel, occurred in 0-23%, depending on the method and the criteria used. A low-response to aspirin, defined by lack of COX-1 inhibition, is a rare phenomenon whereas high residual platelet reactivity as determined by PFA may be a rather frequent finding but is not consistent over time in all patients. A low-response to clopidogrel depends very much on the method and definition used.
Related Concept Videos
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease I: Introduction
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

